e-therapeutics (LSE: ETX)

Last close As at 21/12/2024

10.03

0.08 (0.80%)

Market capitalisation

59m

Edison Investment Research is terminating coverage on e-therapeutics (ETX). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.

Latest Insights

View More

Healthcare | edison tv

e-therapeutics showcase

Healthcare | Update

e-therapeutics — More to come in RNAi therapy discovery

Healthcare | Initiation

e-therapeutics — Enhancing siRNA drug discovery with LLMs

e-therapeutics

Thematics

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free